Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Noncanonical scaffolding of G αi and β-arrestin by G protein-coupled receptors.

Tytuł:
Noncanonical scaffolding of G αi and β-arrestin by G protein-coupled receptors.
Autorzy:
Smith JS; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Pack TF; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Inoue A; Department of Pharmaceutical Sciences, Tohoku University, Japan.
Lee C; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Zheng K; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Choi I; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Eiger DS; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Warman A; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Xiong X; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Ma Z; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Viswanathan G; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Levitan IM; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
Rochelle LK; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Staus DP; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Snyder JC; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Kahsai AW; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Caron MG; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.; Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.; Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA.
Rajagopal S; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. .; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Źródło:
Science (New York, N.Y.) [Science] 2021 Mar 12; Vol. 371 (6534). Date of Electronic Publication: 2021 Jan 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: : Washington, DC : American Association for the Advancement of Science
Original Publication: New York, N.Y. : [s.n.] 1880-
MeSH Terms:
GTP-Binding Protein alpha Subunits, Gi-Go/*metabolism
Receptors, G-Protein-Coupled/*metabolism
beta-Arrestins/*metabolism
Bioluminescence Resonance Energy Transfer Techniques ; Cell Movement ; Extracellular Signal-Regulated MAP Kinases/metabolism ; HEK293 Cells ; Humans ; Signal Transduction
References:
Nat Commun. 2017 Nov 22;8(1):1706. (PMID: 29167435)
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2653-E2662. (PMID: 29487210)
J Biol Chem. 2001 Jun 1;276(22):19452-60. (PMID: 11279203)
Sci Signal. 2018 Nov 06;11(555):. (PMID: 30401786)
ACS Chem Biol. 2016 Feb 19;11(2):400-8. (PMID: 26569370)
Nat Rev Drug Discov. 2018 Apr;17(4):243-260. (PMID: 29302067)
J Biol Chem. 2018 May 11;293(19):7466-7473. (PMID: 29523687)
Nat Struct Mol Biol. 2019 Dec;26(12):1123-1131. (PMID: 31740855)
Cell. 2019 Jun 13;177(7):1933-1947.e25. (PMID: 31160049)
J Biol Chem. 1994 Jan 7;269(1):645-51. (PMID: 8276865)
Nature. 2020 Mar;579(7798):297-302. (PMID: 31945772)
BMC Biol. 2015 Dec 17;13:107. (PMID: 26678094)
Nat Commun. 2018 Jan 23;9(1):341. (PMID: 29362459)
Mol Pharmacol. 2017 Aug;92(2):136-150. (PMID: 28559424)
J Biol Chem. 1999 Nov 5;274(45):32248-57. (PMID: 10542263)
Endocr Rev. 2001 Apr;22(2):153-83. (PMID: 11294822)
Annu Rev Physiol. 2007;69:451-82. (PMID: 17037978)
Nature. 2017 Jul 6;547(7661):68-73. (PMID: 28607487)
J Biol Chem. 2018 Apr 20;293(16):6161-6171. (PMID: 29487132)
J Biol Chem. 1995 Jul 21;270(29):17148-53. (PMID: 7615510)
Nature. 2014 Aug 14;512(7513):218-222. (PMID: 25043026)
Sci Signal. 2018 Sep 25;11(549):. (PMID: 30254056)
Science. 1990 Jun 22;248(4962):1547-50. (PMID: 2163110)
Nature. 2018 May;557(7705):381-386. (PMID: 29720660)
J Biol Chem. 2017 Jun 2;292(22):9150-9163. (PMID: 28416608)
Science. 2005 Apr 22;308(5721):512-7. (PMID: 15845844)
J Biol Chem. 2014 May 16;289(20):14211-24. (PMID: 24668815)
Am J Respir Cell Mol Biol. 2012 Jun;46(6):723-30. (PMID: 22427538)
Mol Pharmacol. 2005 Apr;67(4):1229-36. (PMID: 15635042)
Annu Rev Biochem. 1987;56:615-49. (PMID: 3113327)
Sci Signal. 2017 Jun 20;10(484):. (PMID: 28634209)
J Biol Chem. 2003 Feb 21;278(8):6258-67. (PMID: 12473660)
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1530-5. (PMID: 23297229)
Nature. 1988 Aug 25;334(6184):715-8. (PMID: 2842685)
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14489-94. (PMID: 9405640)
Cell. 2016 Aug 11;166(4):907-919. (PMID: 27499021)
J Biol Chem. 1985 Nov 25;260(27):14428-30. (PMID: 3863818)
Trends Pharmacol Sci. 2007 Aug;28(8):362-5. (PMID: 17629577)
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2562-2567. (PMID: 28223524)
Nature. 2018 May;557(7705):452-456. (PMID: 29720655)
Front Pharmacol. 2019 Feb 19;10:125. (PMID: 30837883)
Nat Chem Biol. 2011 Jul 24;7(9):624-30. (PMID: 21785426)
Nat Chem Biol. 2017 Jul;13(7):799-806. (PMID: 28553949)
Nat Methods. 2012 Oct;9(10):1021-9. (PMID: 22983457)
J Pharmacol Exp Ther. 2010 Dec;335(3):572-9. (PMID: 20801892)
Grant Information:
K22 CA212058 United States CA NCI NIH HHS; F31 DA041160 United States DA NIDA NIH HHS; K08 HL114643 United States HL NHLBI NIH HHS; T32 GM145449 United States GM NIGMS NIH HHS; R01 GM122798 United States GM NIGMS NIH HHS; T32 GM007171 United States GM NIGMS NIH HHS; R37 MH073853 United States MH NIMH NIH HHS
Substance Nomenclature:
0 (Receptors, G-Protein-Coupled)
0 (beta-Arrestins)
EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases)
EC 3.6.5.1 (GTP-Binding Protein alpha Subunits, Gi-Go)
Entry Date(s):
Date Created: 20210122 Date Completed: 20210330 Latest Revision: 20221019
Update Code:
20240105
PubMed Central ID:
PMC8005335
DOI:
10.1126/science.aay1833
PMID:
33479120
Czasopismo naukowe
Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) are common drug targets and canonically couple to specific G α protein subtypes and β-arrestin adaptor proteins. G protein-mediated signaling and β-arrestin-mediated signaling have been considered separable. We show here that GPCRs promote a direct interaction between G αi protein subtype family members and β-arrestins regardless of their canonical G α protein subtype coupling. G αi :β-arrestin complexes bound extracellular signal-regulated kinase (ERK), and their disruption impaired both ERK activation and cell migration, which is consistent with β-arrestins requiring a functional interaction with G αi for certain signaling events. These results introduce a GPCR signaling mechanism distinct from canonical G protein activation in which GPCRs cause the formation of G αi :β-arrestin signaling complexes.
(Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies